Table 1.
Clinical and demographic characteristics of patients before CABG and 5-7 years after CABG.
| Variable | Patients, n=45 | |
|---|---|---|
| Before CABG |
5-7 years after CABG | |
| Age, years, Me (Q25; Q75) | 56.0 (52; 59) | 62.5 (58,5; 66) |
|
Educational attainment, n (%) 8 years 10-12 years 15 years |
2 (4%) 31 (69%) 12 (27%) |
- |
| Left ventricular ejection fraction, %, Me (Q25; Q75) | 60.0 (52; 63) | 60.5 (54; 63) |
| Functional class angina, n (%) 0 I-II III |
0 (0%) 30 (77%) 15 (33%) |
32 (71%) 12 (27%) 1 (2%) |
|
Functional class NYHA, n (%) I-II III |
37 (82%) 8 (18%) |
44 (98%) 1 (2%) |
| Severity of coronary arteries lesions by the SYNTAX scale before surgery, scores, Me (Q25; Q75) | 22.5 (16.5; 29.3) | - |
| History of myocardial infarction, n (%) | 6 (13%) | - |
| Myocardial infarction after surgery, n (%) | - | 1 (2%) |
| Stenoses of the carotid arteries, n (%) | 21 (47%) | 23 (51%) |
| Diabetes mellitus Type 2, n (%) | 10 (22%) | 10 (22%) |
|
Cardiac rate disturbance and disorder of conduction, n (%) Atrial fibrillation Ventricular contractions, III-IV Lown grade |
0 (0%) 0 (0%) |
4 (9%) 7 (16%) |
|
Medication, n (%) ACEi Statin Beta-blockers Antiplatelet drugs CCB Nitrates |
40 (89%) 30 (67%) 44 (98%) 43 (96%) 19 (42%) 7 (16%) |
20 (44%) 31 (69%) 37 (82%) 42 (93%) 0 (0%) 1 (2,2%) |
| MMSE, scores, Me (Q25; Q75) | 28 (26; 28) | 28 (27; 29) |
| FAB, scores, Me (Q25; Q75) | 17 (16; 17) | 16 (15; 17) |
| BDI-II, scores, Me (Q25; Q75) | 2 (1; 3) | 3 (2; 5) |
ACEi=angiotensin-converting enzyme inhibitor; BDI-II=Beck Depression Inventory II; CABG=coronary artery bypass grafting; CCB=calcium channel blockers; FAB=Frontal Assessment Battery; Me=median; MMSE=Mini-Mental State Examination; NYHA=New York Heart Association